Article Text

PDF
Associations between circulating macrophage migration inhibitory factor (MIF) levels and rheumatoid arthritis, and between MIF gene polymorphisms and disease susceptibility: a meta-analysis
  1. Sang-Cheol Bae1,
  2. Young Ho Lee2
  1. 1Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea
  2. 2Division of Rheumatology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea
  1. Correspondence to Professor Young Ho Lee, Division of Rheumatology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Inchon-ro, Seongbuk-gu, Seoul 02841, Republic of Korea; lyhcgh{at}korea.ac.kr

Abstract

Aim To systematically review evidence regarding the relationship between circulating macrophage migration inhibitory factor (MIF) levels and rheumatoid arthritis (RA), and the association between MIF gene polymorphisms and RA susceptibility.

Design We performed a meta-analysis on data of serum/plasma MIF levels in patients with RA and in controls, and on associations between the MIF−173 C/G and −794CATT5-8 polymorphisms and RA susceptibility.

Patients Twelve studies, comprising a total of 362 RA cases and 531 controls evaluated for MIF levels, and 2367 RA cases and 2395 controls evaluated for MIF polymorphisms, were included.

Results MIF levels were significantly higher in the RA group than in the control group (standardised mean difference (95% CI) 0.923 (0.766 to 1.080), p<0.001). Stratification by ethnicity revealed significantly higher MIF levels in the RA group in Caucasian, Asian and Latin American populations. MIF levels were significantly higher in patients with RA, regardless of adjustment, sample size or data type evaluated. RA was identified to be significantly associated with the MIF−173 C allele (OR (95% CI) 1.271 (1.141 to 1.416), p<0.001), as well as with the −794CATT7 allele (OR (95% CI) 1.229 (1.084 to 1.415), p=0.002) and the −794CATT7-MIF-173C haplotype RA (OR (95% CI) 1.433 (1.138 to 1.805), p=0.002).

Conclusions Our meta-analyses revealed significantly higher circulating MIF levels in patients with RA, and found evidence of associations between the MIF−173 C/G and −794CATT5-8 polymorphisms and RA susceptibility.

  • MIF level
  • polymorphism
  • rheumatoid arthritis

Statistics from Altmetric.com

Footnotes

  • Contributors YHL designed the study. SCB and YHL collected data, performed the statistical analysis and drafted the manuscript. All authors read and approved the final manuscript.

  • Funding This study was supported in part by a grant of the Korea Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea (HI15C2958).

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.